All News PeptiDream Inc.

Equities

4587

JP3836750004

Market Closed - Japan Exchange Other stock markets 07:00:00 10/05/2024 BST			5-day change	1st Jan Change
1,962 ^JPY	-0.18%		-1.65%	+31.99%

05-07	Jefferies Adjusts PeptiDream’s Price Target to 1,900 Yen From 1,400 Yen, Keeps at Hold	MT
04-30	Peptidream Announces Expansion of Peptide Discovery Collaboration with Novartis	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Adjusts PeptiDream’s Price Target to 1,900 Yen From 1,400 Yen, Keeps at Hold	05-07	MT
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis	04-30	BU
Peptidream Announces Expansion of Peptide Discovery Collaboration with Novartis	04-30	CI
PeptiDream Inc. Announces Expansion of Peptide Discovery Collaboration with Novartis Pharma AG	04-30	CI
Certain Preferred Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	03-12	CI
Certain Stock Options of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	03-12	CI
Certain Common Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	03-12	CI
PeptiDream to Partake in Bristol Myers' Tender Offer for All RayzeBio Shares	02-15	MT
PeptiDream Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024	02-14	CI
PeptiDream Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-14	CI
Jefferies Adjusts PeptiDream's Price Target to 1,400 Yen From 1,300 Yen, Keeps at Hold	01-24	MT
Linqmed Inc. announced that it has received ¥680 million in funding from a group of investors	12-21	CI
PeptiDream Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	11-09	CI
PeptiDream : Corporate Presentation（November 2023, English version)(2MB)	11-01	PU
PeptiDream : コーポレート・プレゼンテーション(2023年11月、英語版）(2MB)	11-01	PU
Jefferies Downgrades PeptiDream to Hold From Buy, Adjusts Price Target to 1,300 Yen From 1,600 Yen	27/10/23	MT
PeptiDream and Bristol-Myers Squibb to Explore Alternatives as PDL1 Program Faces Setback	27/10/23	MT
Peptidream Announces Update on PDL1 Program Partnered with Bristol-Myers Squibb Company	26/10/23	CI
Jefferies Upgrades PeptiDream to Buy From Hold, Adjusts Price Target to 1,600 Yen From 1,900 Yen	18/10/23	MT
PeptiDream : Sustainability Report 2023(2.9 MB)	27/09/23	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News PeptiDream Inc.

Equities

4587

JP3836750004

All News

Filters